Pdi News (NASDAQ:PDII)
| Latest Pdi News Headlines | | Date | Time | Source | | | 03/07/2007 | 6:19PM | PRNUS | PDI, Inc. to Hold Fourth Quarter 2006 Financial Results Conference Call on Wednesday, March 14, 2007
SADDLE RIVER, N.J., March 7 /PRNewswire-FirstCall/ -- PDI, Inc. (NASDAQ:PDII), a diversified sales and marketing services provider to the biopharmaceutical industry, today announced that it will release its fourth quarter 2006 financial results on Wednesday, March 14, 2007 after market close.
PDI will host an investment... More...>> |
| 11/07/2006 | 4:15PM | PRNUS | PDI, Inc. Reports Third Quarter and Nine Month 2006 Financial Results and Comments on Recently Completed Strategic Plan
PDI Board Approves Common Stock Repurchase Program
SADDLE RIVER, N.J., Nov. 7 /PRNewswire-FirstCall/ -- PDI, Inc. (NASDAQ:PDII) a contract sales and marketing services provider to the pharmaceutical industry, today announced its third quarter and nine month 2006 financial results and a common stock repurchase program... More...>> |
| 11/07/2006 | 4:15PM | PRNUS | PDI, Inc. Reports Third Quarter and Nine Month 2006 Financial Results and Comments on Recently Completed Strategic Plan
PDI Board Approves Common Stock Repurchase Program
SADDLE RIVER, N.J., Nov. 7 /PRNewswire-FirstCall/ -- PDI, Inc. (NASDAQ:PDII) a contract sales and marketing services provider to the pharmaceutical industry, today announced its third quarter and nine month 2006 financial results and a common stock repurchase program... More...>> |
| 11/06/2006 | 2:50PM | PRNUS | PDI, Inc. Announces Appointment of David N. Stievater as Senior Vice President, Emerging Pharma
SADDLE RIVER, N.J., Nov. 6 /PRNewswire-FirstCall/ -- PDI, Inc. (NASDAQ:PDII) a contract sales and marketing services provider to the pharmaceutical industry, today announced the appointment of David N. Stievater to the newly created position of Senior Vice President, Emerging Pharma reporting directly to Mr. Michael... More...>> |
| 10/25/2006 | 7:00AM | PRNUS | PDI, Inc. Comments on Status of sanofi-aventis Fee for Service Contract Sales Program
SADDLE RIVER, N.J., Oct. 25 /PRNewswire-FirstCall/ -- PDI, Inc. (NASDAQ:PDII) a contract sales and marketing services provider to the pharmaceutical industry, today announced that it has received notification from sanofi-aventis of its intention to terminate its contract sales engagement with PDI effective December... More...>> |
| 10/18/2006 | 10:42AM | PRNUS | PDI, Inc. Announces Date for Release of Third Quarter 2006 Financial Results
SADDLE RIVER, N.J., Oct. 18 /PRNewswire-FirstCall/ -- PDI, Inc. (NASDAQ:PDII) a diversified sales and marketing services provider to the biopharmaceutical industry, announced today its intention to release its third quarter 2006 financial results on Tuesday, November 7, 2006 after the close of trading via press release... More...>> |
| 09/26/2006 | 7:00AM | PRNUS | PDI, Inc. Comments on Status of GlaxoSmithKline Fee for Service Contract Sales Program
SADDLE RIVER, N.J., Sept. 26 /PRNewswire-FirstCall/ -- PDI, Inc. (NASDAQ:PDII) a contract sales and marketing services provider to the biopharmaceutical industry, today announced that it has received verbal notification from GlaxoSmithKline (GSK) of its intention not to renew its contract sales engagement with PDI for... More...>> |
| 08/01/2006 | 6:43PM | PRNUS | PDI, Inc. Reports Second Quarter and Six Month 2006 Results
SADDLE RIVER, N.J., Aug. 1 /PRNewswire-FirstCall/ -- PDI, Inc. (NASDAQ:PDII) a contract sales and marketing services provider to the pharmaceutical industry, today announced its second quarter and six month 2006 results.
Continuing Operations
Results from continuing operations were:
For... More...>> |
| 07/10/2006 | 10:48AM | PRNUS | PDI, Inc. Announces Date for Release of Second Quarter 2006 Financial Results
SADDLE RIVER, N.J., July 10 /PRNewswire-FirstCall/ -- PDI, Inc. (NASDAQ:PDII) a diversified sales and marketing services provider to the biopharmaceutical industry, announced today its intention to release its second quarter 2006 financial results on Tuesday, August 1, 2006 after the close of trading via press release... More...>> |
| 05/12/2006 | 7:30AM | PRNUS | PDI Announces Appointment of Jeffrey E. Smith as Chief Financial Officer
SADDLE RIVER, N.J., May 12 /PRNewswire-FirstCall/ -- PDI, Inc. (NASDAQ:PDII), a contract sales and marketing services provider to the biopharmaceutical industry, today announced that its Board of Directors has appointed Jeffrey E. Smith as Executive Vice President, Chief Financial Officer and Treasurer. Mr. Smith will... More...>> |
| 05/11/2006 | 6:38PM | PRNUS | PDI, Inc. Announces a Significant New Contract Sales Engagement With a Major Pharmaceutical Company
SADDLE RIVER, N.J., May 11 /PRNewswire-FirstCall/ -- PDI, Inc. (NASDAQ:PDII), a contract sales and marketing services provider to the biopharmaceutical industry, today announced that it has signed an agreement with a major pharmaceutical company for a new contract sales engagement. The contract, effective immediately... More...>> |
| 05/08/2006 | 7:38AM | PRNUS | PDI Announces Appointment of Michael J. Marquard as Chief Executive Officer
SADDLE RIVER, N.J., May 8 /PRNewswire-FirstCall/ -- PDI, Inc. (NASDAQ: PDII), a contract sales and marketing services provider to the biopharmaceutical industry, today announced that the Board of Directors has appointed Michael J. Marquard as Chief Executive Officer. Mr. Marquard, who will join the Company effective... More...>> |
| 05/01/2006 | 6:35PM | PRNUS | PDI, Inc. Reports First Quarter 2006 Financial Results
SADDLE RIVER, N.J., May 1 /PRNewswire-FirstCall/ -- PDI, Inc. (NASDAQ:PDII) a contract sales and marketing services provider to the biopharmaceutical industry, announced today its first quarter 2006 financial results.
First Quarter Results
Revenue for the quarter ended March 31, 2006 was $78.8 million, 3.9% less than... More...>> |
| 04/10/2006 | 2:04PM | PRNUS | PDI, Inc. Announces Date for Release of First Quarter 2006 Financial Results
SADDLE RIVER, N.J., April 10 /PRNewswire-FirstCall/ -- PDI, Inc. (NASDAQ:PDII) a diversified sales and marketing services provider to the biopharmaceutical industry, announced today its intention to release its first quarter 2006 financial results on Monday, May 1, 2006 after the close of trading via press release... More...>> |
| 03/02/2006 | 6:31AM | PRNUS | PDI Reports Fourth Quarter and Year End 2005 Financial Results
SADDLE RIVER, N.J., March 1 /PRNewswire-FirstCall/ -- PDI, Inc. (NASDAQ:PDII) a diversified sales and marketing services provider to the biopharmaceutical industry, announced today its fourth quarter and year end 2005 financial results.
Twelve Months Results
Revenues for the twelve months ended December 31, 2005 was... More...>> |
| 03/01/2006 | 11:53PM | PRNUS | PDI Reports Fourth Quarter and Year End 2005 Financial Results
SADDLE RIVER, N.J., March 1 /PRNewswire-FirstCall/ -- PDI, Inc. (NASDAQ:PDII) a diversified sales and marketing services provider to the biopharmaceutical industry, announced today its fourth quarter and year end 2005 financial results.
Twelve Months Results
Revenues for the twelve months ended December 31, 2005 was... More...>> |
| 02/28/2006 | 7:00AM | PRNUS | PDI, Inc. Announces Termination of AstraZeneca Fee-for-Service Contract Sales Programs
SADDLE RIVER, N.J., Feb. 28 /PRNewswire-FirstCall/ -- PDI, Inc. (NASDAQ:PDII) a diversified sales and marketing services provider to the biopharmaceutical industry, announced today that it has been notified by AstraZeneca that its fee-for-service agreements will be terminated effective April 30, 2006. The termination... More...>> |
| 02/13/2006 | 12:48PM | PRNUS | PDI, Inc. Announces Date for Release of Fourth Quarter and Year End 2005 Financial Results
SADDLE RIVER, N.J., Feb. 13 /PRNewswire-FirstCall/ -- PDI, Inc. (NASDAQ:PDII) a diversified sales and marketing services provider to the biopharmaceutical industry, announced today its intention to release its fourth quarter and year end 2005 financial results on Wednesday, March 1, 2006 after the close of trading via... More...>> |
| 02/10/2006 | 7:15AM | PRNUS | PDI, Inc. Comments on Status of AstraZeneca
Fee for Service Contract Sales Programs
SADDLE RIVER, N.J., Feb. 10 /PRNewswire-FirstCall/ -- PDI, Inc. (NASDAQ:PDII) a diversified sales and marketing services provider to the biopharmaceutical industry, announced today that it is engaged in discussions with AstraZeneca regarding the status of their fee for service... More...>> |
| 02/03/2006 | 3:35PM | PRNUS | PDI, Inc. to Present at UBS Global Healthcare Services Conference
SADDLE RIVER, N.J., Feb. 3 /PRNewswire-FirstCall/ -- PDI, Inc. (NASDAQ:PDII) a diversified sales and marketing services provider to the biopharmaceutical industry, announced today that Stephen P. Cotugno, Executive Vice President, Corporate Development, will present an overview of the Company's strategic plans and recent... More...>> |
|
|
|